FDA.reportPublic FDA data

Trilipix 135 MG Delayed Release Oral Capsule

RxCUI
828377
RxNorm name
Trilipix 135 MG Delayed Release Oral Capsule
Display name
Trilipix 135 MG Delayed Release Oral Capsule
Full name
Trilipix 135 MG Delayed Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3057fc9c-ff77-43eb-b687-776660423742Trilipix 135 MG Delayed Release Oral Capsule [PSN] · fenofibric acid 135 MG Delayed Release Oral Capsule [Trilipix] [SBD] · Trilipix 135 MG Delayed Release Oral Capsule [SY]31These highlights do not include all the information needed to use Trilipix safely and effectively. See full prescribing information for Trilipix. Trilipix (fenofibric acid) capsule, delayed release for oral use Initial U.S. Approval: 200820111214